DeutschNewstral
Article
Fft.com on 2024-05-02 10:12
Novo Nordisk AS: Novo Nordisk raises profit forecast on high demand for weight loss drugs
Related news
- FNovo Nordisk AS: Novo Nordisk ‘surprised’ by high European demand for weight-loss drugsft.com
Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales SoarForbes
Novo Nordisk AS: Novo Nordisk raises profit guidance as weight-loss drug sales boomFinancial Times- FNovo Nordisk AS: Novo warns of growing competition as weight-loss drugs power profitsft.com
- Novo Nordisk AS: Novo Nordisk’s sales of weight loss drugs soarFinancial Times
- Novo Nordisk AS: Novo Nordisk to test weight-loss drugs’ effect on alcohol use and liver diseaseFinancial Times
- Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyForbes
Novo Nordisk prioritizes existing patients for weight-loss drug as demand soarsPolitico.eu
Growing demand for weight loss treatments drives sales at drugmaker Novo NordiskShropshire Star- FNovo Nordisk slashes profit target, shares plungeft.com
Sales skyrocket for weight-loss drug firm Novo Nordiskeuronews- FNovo Nordisk AS: Novo Nordisk signs deals worth up to $1bn with US biotechs in race for obesity drugsft.com
- LWeight Loss and Obesity Management Market 2022-2027: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth| Novo Nordisk, GlaxoSmithKline, Rocheliverpoolstudentmedia.com
- MNovo Nordisk profit beats on strength in diabetes, obesity treatmentsmarketwatch.com
Novo Nordisk net profit jumps on diabetes, obesity treatmentstimesofmalta.com- Novo Nordisk profits up on diabetes, obesity drugstimesofmalta.com
- Novo Nordisk AS: Novo Nordisk’s weight loss jab Wegovy cuts risk of stroke by 20%Financial Times
- Novo Nordisk AS: Prescriptions surge for Novo Nordisk’s Ozempic and similar drugsFinancial Times
- INovo Nordisk results: profits grow by over 30% off the back of weight-loss brand WeGovyinvezz.com